A detailed history of Wespac Advisors So Cal, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wespac Advisors So Cal, LLC holds 28,288 shares of NVO stock, worth $3.06 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
28,288
Holding current value
$3.06 Million
% of portfolio
0.79%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$119.07 - $145.42 $3.37 Million - $4.11 Million
28,288 New
28,288 $3.37 Million
Q2 2019

Jul 30, 2019

SELL
$46.79 - $52.47 $22,459 - $25,185
-480 Closed
0 $0
Q3 2018

Oct 22, 2018

BUY
$46.76 - $51.24 $22,444 - $24,595
480 New
480 $22,000
Q2 2018

Jul 13, 2018

SELL
$44.29 - $50.42 $21,259 - $24,201
-480 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
480
480 $20,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wespac Advisors So Cal, LLC Portfolio

Follow Wespac Advisors So Cal, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.